IRON (Disc Medicine) Market Cap: $2,813.17 Mil (As of Jun. 26, 2026)


IRON Disc Medicine Inc IRON
34 GF Score
Price $73.65
! 3 Warning Signs
View Full Analysis

What is Disc Medicine Market Cap?

Disc Medicine IRON +5.09% 34 Market Cap is $2,813.17 Mil as of Jun. 26, 2026. GuruFocus rates IRON with a GF Score™ of 34/100. The stock has 3 warning signs investors should review. Among 1,431 Biotechnology companies, Disc Medicine ranks better than 90.92% on this metric.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Disc Medicine's share price for the quarter that ended in Mar. 2026 was $63.94. Disc Medicine's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 38.19 Mil. Therefore, Disc Medicine's market cap for the quarter that ended in Mar. 2026 was $2,441.87 Mil.

Disc Medicine's quarterly market cap increased from Sep. 2025 ($2,313.26 Mil) to Dec. 2025 ($3,008.92 Mil) but then declined from Dec. 2025 ($3,008.92 Mil) to Mar. 2026 ($2,441.87 Mil).

Disc Medicine's annual market cap increased from Dec. 2023 ($1,407.03 Mil) to Dec. 2024 ($1,893.44 Mil) and increased from Dec. 2024 ($1,893.44 Mil) to Dec. 2025 ($3,008.92 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Disc Medicine's Enterprise Value for Today is $2,114.08 Mil.


Disc Medicine  (NAS:IRON) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Disc Medicine Market Cap Related Terms


Disc Medicine Market Cap Historical Data

* Premium members only.

The historical data trend for Disc Medicine's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Disc Medicine Market Cap Chart

Disc Medicine Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Market Cap
Get a 7-Day Free Trial 125.74 346.15 1,407.03 1,893.44 3,008.92

Disc Medicine Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,716.60 1,837.45 2,313.26 3,008.92 2,441.87

IRON vs DFTX, ARQT, MLYS: Market Cap Comparison

For the Biotechnology subindustry, Disc Medicine's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Disc Medicine Market Cap vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Disc Medicine's Market Cap distribution charts can be found below:

* The bar in red indicates where Disc Medicine's Market Cap falls into.


IRON
34GF Score
Disc Medicine Inc IRON
Market Cap is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Disc Medicine Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Disc Medicine's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as

Market Cap (A: Dec. 2025 )=Share Price (A: Dec. 2025 )*Shares Outstanding (EOP) (A: Dec. 2025 )
=$79.41*37.891
=$3,008.92

Disc Medicine's Market Cap for the quarter that ended in Mar. 2026 is calculated as

Market Cap (Q: Mar. 2026 )=Share Price (Q: Mar. 2026 )*Shares Outstanding (EOP) (Q: Mar. 2026 )
=$63.94*38.190
=$2,441.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of $2,813.17 Mil mean?
Disc Medicine (IRON) has a Market Cap of $2,813.17 Mil as of Jun. 26, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Disc Medicine and its competitors. According to the industry distribution chart, Disc Medicine ranks #130 out of 1431 companies in the Biotechnology industry, placing it in the top 9.1%.
Is Disc Medicine's Market Cap too high?
Disc Medicine's current Market Cap is $2,813.17 Mil. The Biotechnology industry median Market Cap is 113.83. Disc Medicine's value of $2,813.17 Mil is 2371.5% above this industry median. Based on the distribution chart, Disc Medicine ranks #130 out of 1431 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Disc Medicine has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Disc Medicine's Market Cap compare to DFTX and ARQT?
According to the Biotechnology industry distribution chart, Disc Medicine ranks #130 out of 1431 companies for Market Cap. This places Disc Medicine in the top 9% of its industry — outperforming the majority of peers. The industry median Market Cap is 113.83. Disc Medicine's value of $2,813.17 Mil is 2371.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 113.83, based on 1,431 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Disc Medicine's current Market Cap of $2,813.17 Mil is 2371.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Disc Medicine and its competitors. For the Biotechnology industry, the median Market Cap is 113.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Disc Medicine's current Market Cap is $2,813.17 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Disc Medicine stock overvalued right now?
Disc Medicine (IRON) has a current Market Cap of $2,813.17 Mil. The current Market Cap is $2,813.17 Mil and 2371.5% above the Biotechnology industry median of 113.83. Disc Medicine's overall GF Score™ is 34/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Disc Medicine (IRON), the current Market Cap is $2,813.17 Mil as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Disc Medicine Business Description

Address 321 Arsenal Street, Suite 101, Watertown, MA, USA, 02472
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
34GF Score

Get the complete analysis for IRON

Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$73.65
Price